Periostin secreted by cancer-associated fibroblasts promotes cancer progression and drug resistance in non-small cell lung cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Periostin secreted by cancer-associated fibroblasts promotes cancer progression and drug resistance in non-small cell lung cancer
Authors
Keywords
-
Journal
JOURNAL OF MOLECULAR MEDICINE-JMM
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-13
DOI
10.1007/s00109-023-02384-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Drug repositioning of tranilast to sensitize a cancer therapy by targeting cancer‐associated fibroblast
- (2022) Kosuke Ochi et al. CANCER SCIENCE
- TNMplot.com: A Web Tool for the Comparison of Gene Expression in Normal, Tumor and Metastatic Tissues
- (2021) Áron Bartha et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- High serum levels of periostin are associated with a poor survival in breast cancer
- (2020) Tilman D. Rachner et al. BREAST CANCER RESEARCH AND TREATMENT
- DIVERSITY AND BIOLOGY OF CANCER-ASSOCIATED FIBROBLASTS
- (2020) Giulia Biffi et al. PHYSIOLOGICAL REVIEWS
- Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma
- (2020) Nayoung Kim et al. Nature Communications
- Heterogeneity of cancer‐associated fibroblasts: Opportunities for precision medicine
- (2020) Ryu Kanzaki et al. CANCER SCIENCE
- Prognostic Significance of Stromal Periostin Expression in Non-Small Cell Lung Cancer
- (2020) Katarzyna Ratajczak-Wielgomas et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting Tumor Microenvironment for Cancer Therapy
- (2019) Catarina Roma-Rodrigues et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance
- (2019) Micol Eleonora Fiori et al. Molecular Cancer
- Role of cancer-associated fibroblasts in tumor structure, composition and the microenvironment in ovarian cancer (Review)
- (2019) Wei Sun et al. Oncology Letters
- Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer
- (2019) Alessandro Leonetti et al. BRITISH JOURNAL OF CANCER
- Identification of Serum Periostin as a Potential Diagnostic and Prognostic Marker for Colorectal Cancer
- (2018) Dong Dong et al. Clinical Laboratory
- Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer
- (2018) Shang-Gin Wu et al. Molecular Cancer
- Periostin: A Matricellular Protein With Multiple Functions in Cancer Development and Progression
- (2018) Laura González-González et al. Frontiers in Oncology
- Periostin is a negative prognostic factor and promotes cancer cell proliferation in non-small cell lung cancer
- (2018) Toshimasa Okazaki et al. Oncotarget
- Turning foes to friends: targeting cancer-associated fibroblasts
- (2018) Xueman Chen et al. NATURE REVIEWS DRUG DISCOVERY
- Effects of lentivirus-mediated silencing of Periostin on tumor microenvironment and bone metastasis via the integrin-signaling pathway in lung cancer
- (2017) Jing Che et al. LIFE SCIENCES
- Predictive and prognostic value of serum periostin in advanced non–small cell lung cancer patients receiving chemotherapy
- (2017) Yan Zhang et al. TUMOR BIOLOGY
- Periostin promotes epithelial-mesenchymal transition via the MAPK/miR-381 axis in lung cancer
- (2017) Wei-Wei Hu et al. Oncotarget
- Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer
- (2016) Bowen Du et al. MOLECULES
- Periostin and tumor-stroma interactions in non-small cell lung cancer
- (2016) Ulrich Nitsche et al. Oncology Letters
- Diagnostic and prognostic value of serum periostin in patients with non-small cell lung cancer
- (2016) Chun-Hua Xu et al. Oncotarget
- TGFβ3-mediated induction of Periostin facilitates head and neck cancer growth and is associated with metastasis
- (2016) Xing Qin et al. Scientific Reports
- Combined EGFR/MEK Inhibition Prevents the Emergence of Resistance in EGFR-Mutant Lung Cancer
- (2015) E. M. Tricker et al. Cancer Discovery
- Differences between CAFs and their paired NCF from adjacent colonic mucosa reveal functional heterogeneity of CAFs, providing prognostic information
- (2014) Mireia Berdiel-Acer et al. Molecular Oncology
- AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer
- (2014) D. A. E. Cross et al. Cancer Discovery
- High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy
- (2013) Y. Lv et al. EJSO
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- Overexpression of periostin predicts poor prognosis in non-small cell lung cancer
- (2013) LING-ZHI HONG et al. Oncology Letters
- The multifaceted role of periostin in tumorigenesis
- (2009) Kai Ruan et al. CELLULAR AND MOLECULAR LIFE SCIENCES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started